▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #635 by analyst upside · 2026-09-27
MGTX
MeiraGTx Holdings plc
Healthcare · Market Cap $1B · P/E 13.3x
ANALYST PRICE TARGET
+154.4%
implied upside to consensus target
Current Price $10.91
Consensus Target $27.75
Bull Target $50.0
Bear Target $16.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
5
Hold
1
Sell
0
52-Week Low $6.62
52-Week High $15.35
YTD Return +39.7%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 13.3x
Forward P/E N/A
EPS (TTM) $0.82
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $398M
Profit Margin 19.9%
52-WEEK RANGE
52-Week Low $6.62
52-Week High $15.35
Current Price $10.91
Bear Target $16.0
Bull Target $50.0
● Now $10.91 ● Target $27.75
TRADING DATA
Avg Volume 786K
YTD Return +39.7%
Analyst Count 8
Consensus Buy
Upside to Target +154.4%
Last Updated 2026-09-27

ANALYST SUMMARY

MeiraGTx Holdings plc (MGTX) is currently trading at $10.91 with a Wall Street consensus price target of $27.75, implying potential upside of 154.4% over the next 12 months. 8 analysts currently cover MGTX, with a consensus rating of Buy - 88% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $50.0, while the most cautious has a target of $16.0.

MGTX operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 39.7% year-to-date and is currently trading near the lower end of its 52-week range of $6.62 – $15.35.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

APMD +138.7%
Apnimed, Inc.
$878M · P/E 3.7x · Buy
VOR +110.6%
Vor Biopharma Inc.
$1B · P/E 0.1x · Buy
COLL +117.5%
Collegium Pharmaceutical, Inc.
$698M · P/E 17.7x · Buy
ZVRA +126.4%
Zevra Therapeutics, Inc.
$656M · P/E 11.9x · Buy
GTBIF +106.5%
Green Thumb Industries Inc.
$2B · P/E 14.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MGTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs ● Initiated
Neutral 2026-09-24 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-08-14 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-08 Building track record
HC Wainwright & Co. reit
Buy → Buy 2026-07-08 31% win rate (48 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-05-15 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-04-22 14% win rate (7 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-04-17 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-01 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
17/30
Consensus clarity
0/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →